Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04775485
Title A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma (FIREFLY-1)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Day One Biopharmaceuticals, Inc.
Age Groups: adult | child
Covered Countries USA | DEU | CAN

Additional content available in CKB BOOST